p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload - PubMed (original) (raw)
. 2007 Mar 22;446(7134):444-8.
doi: 10.1038/nature05602. Epub 2007 Mar 4.
Tohru Minamino, Haruhiro Toko, Hideyuki Miyauchi, Masayuki Orimo, Yingjie Qin, Hiroshi Akazawa, Kaoru Tateno, Yosuke Kayama, Mutsuo Harada, Ippei Shimizu, Takayuki Asahara, Hirofumi Hamada, Shuhei Tomita, Jeffrey D Molkentin, Yunzeng Zou, Issei Komuro
Affiliations
- PMID: 17334357
- DOI: 10.1038/nature05602
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano et al. Nature. 2007.
Abstract
Cardiac hypertrophy occurs as an adaptive response to increased workload to maintain cardiac function. However, prolonged cardiac hypertrophy causes heart failure, and its mechanisms are largely unknown. Here we show that cardiac angiogenesis is crucially involved in the adaptive mechanism of cardiac hypertrophy and that p53 accumulation is essential for the transition from cardiac hypertrophy to heart failure. Pressure overload initially promoted vascular growth in the heart by hypoxia-inducible factor-1 (Hif-1)-dependent induction of angiogenic factors, and inhibition of angiogenesis prevented the development of cardiac hypertrophy and induced systolic dysfunction. Sustained pressure overload induced an accumulation of p53 that inhibited Hif-1 activity and thereby impaired cardiac angiogenesis and systolic function. Conversely, promoting cardiac angiogenesis by introducing angiogenic factors or by inhibiting p53 accumulation developed hypertrophy further and restored cardiac dysfunction under chronic pressure overload. These results indicate that the anti-angiogenic property of p53 may have a crucial function in the transition from cardiac hypertrophy to heart failure.
Similar articles
- Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
Sakamoto M, Minamino T, Toko H, Kayama Y, Zou Y, Sano M, Takaki E, Aoyagi T, Tojo K, Tajima N, Nakai A, Aburatani H, Komuro I. Sakamoto M, et al. Circ Res. 2006 Dec 8;99(12):1411-8. doi: 10.1161/01.RES.0000252345.80198.97. Epub 2006 Nov 9. Circ Res. 2006. PMID: 17095722 - Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
Hilfiker-Kleiner D, Hilfiker A, Kaminski K, Schaefer A, Park JK, Michel K, Quint A, Yaniv M, Weitzman JB, Drexler H. Hilfiker-Kleiner D, et al. Circulation. 2005 Sep 6;112(10):1470-7. doi: 10.1161/CIRCULATIONAHA.104.518472. Epub 2005 Aug 29. Circulation. 2005. PMID: 16129800 - [P53 and its role in the development of heart failure].
Sano M, Komuro I. Sano M, et al. Nihon Rinsho. 2008 May;66(5):1013-21. Nihon Rinsho. 2008. PMID: 18464525 Review. Japanese. - Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice.
Zou Y, Li J, Ma H, Jiang H, Yuan J, Gong H, Liang Y, Guan A, Wu J, Li L, Zhou N, Niu Y, Sun A, Nakai A, Wang P, Takano H, Komuro I, Ge J. Zou Y, et al. J Mol Cell Cardiol. 2011 Nov;51(5):821-9. doi: 10.1016/j.yjmcc.2011.07.030. Epub 2011 Aug 7. J Mol Cell Cardiol. 2011. PMID: 21854784 - Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy.
Toko H, Minamino T, Komuro I. Toko H, et al. Trends Cardiovasc Med. 2008 Apr;18(3):88-93. doi: 10.1016/j.tcm.2008.01.003. Trends Cardiovasc Med. 2008. PMID: 18436146 Review.
Cited by
- The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism.
Chen Q, Wang WY, Xu QY, Dai YF, Zhu XY, Chen ZY, Sun N, Leung CH, Gao F, Wu KJ. Chen Q, et al. J Cell Mol Med. 2024 Oct;28(19):e70124. doi: 10.1111/jcmm.70124. J Cell Mol Med. 2024. PMID: 39351650 Free PMC article. - Gastrodin Alleviates Angiotensin II-Induced Hypertension and Myocardial Apoptosis via Inhibition of the PRDX2/p53 Pathway In Vivo and In Vitro.
Xu N, Xie Q, Chen Y, Li J, Zhang X, Zheng H, Cheng Y, Wu M, Shen A, Wei L, Yao M, Yang Y, Sferra TJ, Jafri A, Fang Y, Peng J. Xu N, et al. Pharmaceuticals (Basel). 2024 Sep 12;17(9):1200. doi: 10.3390/ph17091200. Pharmaceuticals (Basel). 2024. PMID: 39338362 Free PMC article. - Endothelial derived, secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodeling.
Keles M, Grein S, Froese N, Wirth D, Trogisch FA, Wardman R, Hemanna S, Weinzierl N, Koch PS, Uhlig S, Lomada S, Dittrich GM, Szaroszyk M, Haustein R, Hegermann J, Martin-Garrido A, Bauersachs J, Frank D, Frey N, Bieback K, Cordero J, Dobreva G, Wieland T, Heineke J. Keles M, et al. Mol Ther Nucleic Acids. 2024 Aug 15;35(3):102306. doi: 10.1016/j.omtn.2024.102306. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39281699 Free PMC article. - Unveiling circRNA-mediated ceRNA networks in ischemic stroke by integrative analysis of multi-source gene expression profiling.
Zhang Y, Zhang XO. Zhang Y, et al. Heliyon. 2024 Aug 27;10(17):e36988. doi: 10.1016/j.heliyon.2024.e36988. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281538 Free PMC article. - Metabolite signaling in the heart.
Flam E, Arany Z. Flam E, et al. Nat Cardiovasc Res. 2023 Jun;2(6):504-516. doi: 10.1038/s44161-023-00270-6. Epub 2023 May 25. Nat Cardiovasc Res. 2023. PMID: 39195876 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous